Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sebnem Batur is active.

Publication


Featured researches published by Sebnem Batur.


Journal of Child Neurology | 2014

Primary diffuse leptomeningeal gliomatosis mimicking tuberculous meningitis.

Muhammet Kosker; Dicle Sener; Omer Kilic; Zehra Isik Hasiloglu; Civan Islak; Ali Metin Kafadar; Sebnem Batur; Buge Oz; Haluk Çokuğraş; Necla Akçakaya; Yildiz Camcioglu

Primary diffuse leptomeningeal gliomatosis is a disease with an aggressive course that can result in death. To date, 82 cases have been reported. Here, the case of a 3-year-old male patient presenting with strabismus, headache, and restlessness is reported. Physical examination revealed paralysis of the left abducens nerve, neck stiffness, and bilateral papilledema. Tuberculous meningitis was tentatively diagnosed, and antituberculosis treatment was initiated when cranial imaging revealed contrast enhancement around the basal cistern. Craniocervical magnetic resonance imaging (MRI) was performed when there was no response to treatment, and it revealed diffuse leptomeningeal contrast enhancement around the basilar cistern, in the supratentorial and infratentorial compartments, and in the spinal region. Primary diffuse leptomeningeal gliomatosis was diagnosed by a meningeal biopsy.


Asian Pacific Journal of Cancer Prevention | 2013

Increase in the Rate of HPV Positive Oropharyngeal Cancers During 1996-2011 in a Case Study in Turkey

Deniz Tural; Olgun Elicin; Sebnem Batur; Deniz Arslan; Buge Oz; Suheyla Serdengecti; Omer Uzel

BACKGROUND Primary aim of this study is to assess whether or not there is an increase at rate of HPV positive oropharyngeal cancers during 1996-2011 in Turkey, for comparison with prior reports from Western countries. MATERIALS AND METHODS A total of 138 newly diagnosed patients with oropharyngeal cancer were identified, 39 of which had no primary tumor specimen available and 18 patients with invalid HPV status, therefore HPV status for remaining 81 patients was evaluated. The presence and type of HPV DNA were determined with formalin- fixed paraffin embedded specimens, using an HPV DNA-based multiplex PCR assay. Associations between HPV status and clinicopathological characteristics were evaluated using a two-sample t-test for the continuous variables and the categorical variables were compared by chi-square test. Overall survival (OS) periods were calculated with Kaplan-Meier method. RESULTS The proportion of HPV-positive cancer has continued to increase during 2004-2011 as compared with 1996-2003. Notably, 33% (6/18) of the cases were HPV-positive in 1996-1999, 43% (9/21) in 2000-2003, 55% (11/20) in 2004-2007 and 70% (16/23) in 2008-2011. Thus, when we compared the results obtained during the 2004-2011with results of 1996-2003 period, we found that increase at HPV-positivity ratio was statistically significant (38% vs 64% p=0.012). CONCLUSIONS This study demonstrated that HPV positive oropharyngeal cancers are increasing in Turkish patients as in the Western world.


Bosnian Journal of Basic Medical Sciences | 2016

Microsatellite instability and B-type Raf proto-oncogene mutation in colorectal cancer: Clinicopathological characteristics and effects on survival

Sebnem Batur; Dogu Vuralli Bakkaloglu; Nuray Kepil; Sibel Erdamar

Prognostic significance of microsatellite instability (MSI) status and B-type Raf proto-oncogene (BRAF) mutation in colorectal cancer is controversial. The aim of this study was to examine the clinical and pathological characteristics associated with microsatellite stability and the effect of MSI and BRAF mutation on the survival of patients with colorectal cancer. The study included 145 colorectal cancer cases. All the patients were examined for DNA mismatch repair (MMR) proteins with an immunohistochemical method. Molecular assessment of MSI was available in a subset of 41 patients. In addition, BRAF mutation analysis was performed in 30 cases. Immunohistochemically, MMR deficiency was present in 28 (19.3%) patients. Female gender (p = 0.001), lesion size ≥5 cm (p = 0.013), Crohn-like response (p = 0.035), and right-sided localization (p < 0.001) were significantly more frequent among MMR-deficient patients. The overall survival was 44.1 ± 5.1 months (95% confidence interval [CI], 33.7-54.4). Multivariate analyses identified only high tumor grade as an independent predictor of poor overall survival: odd ratio, 6.7 (95% CI 2.1-21.7), p = 0.002. In the subset of patients with available BRAF assessment (n = 30), a negative BRAF status was associated with better survival when compared to a positive BRAF status (36.7 ± 2.1 vs. 34.1 ± 7.2 months, p = 0.048). The sensitivity and specificity of the immunohistochemical method in predicting positive MSI status, with the molecular method as a reference, were 85.7% (95% CI: 56.2%-97.5%) and 88.9% (95% CI: 69.7%-97.1%), respectively. BRAF appears to be a significant predictor of a worse outcome in patients with colorectal cancer. Further studies with a large spectrum of clinical and biological variables are warranted.


Turkish Journal of Pathology | 2013

Interobserver Agreement Among Histological Patterns and Diagnosis in Lung Adenocarcinomas

Halide Nur Ürer; Rengin Ahıskalı; Naciye Arda; Sebnem Batur; Leyla Cinel; Gerhard Dekan; Neslihan Fener; Pinar Firat; Silvana Geleff; Buge Oz; Yasemin Ozluk; Kursat Yildiz; Emine Dilek Yılmazbayhan; Handan Zeren; Atilla Uysal

Abstract Objective: The aim of this study was to investigate the interobserver agreement in determination of the dominant histological pattern and the final diagnosis in lung adenocarcinomas. Material and Method: A total of 12 patients with a diagnosis of primary lung adenocarcinoma were included in the study. Twelve pathologists from eight study centers were asked first to determine the dominant histological pattern in these cases and then to decide whether the final diagnosis was in situ, minimally invasive or invasive adenocarcinoma. Results: The kappa value for the agreement in determining the dominant pattern among the pathologists was 0.36 (p<0.001), with the values for the lepidic, acinar, papillary, solid, micropapillary patterns and mucinous character of adenocarcinoma being 0.34, 0.28, 0.30, 0.80, 0.16 and 0.38 respectively (p<0.001, p<0.001, p<0.001, p<0.001, p<0.001, p<0.001). None of the cases was diagnosed as in situ adenocarcinoma. On the other hand, the kappa value for the agreement in differentiating minimally invasive from invasive adenocarcinoma among reviewers was 0.17 (p<0.001). Conclusion: The agreement among pathologists in determining the subtype of lung adenocarcinomas that depends on the identification of the dominant pattern was at intermediate level. In addition, the agreement in deciding whether the case is minimally invasive or invasive, was at low level. The criteria defining the histological patterns should be clarified and described in more detail. Educational activities and larger multicenter studies might be helpful in improving the agreement and standardization. ÖZ Amaç: Bu calışmanın amacı, akciğer adenokarsinomunda baskın histolojik patern belirlemede ve nihai tanı konusunda değerlendiriciler arası uyumun araştırılmasıdır. Gereç ve Yöntem: Komplet cerrahi rezeksiyon uygulanan ve mikst tipte primer akciğer adenokarsinom tanılı 12 olgu calışmaya alındı. Calışma sekiz merkezden 12 patologun katılımı ile yapıldı. Değerlendiricilerden baskın patern tayini ile son tanı olarak invaziv adenokarsinom, minimal invaziv adenokarsinom arasında secim yapmaları istendi. Bulgular: Patologlar arasında baskın patern uyumunda kappa değeri 0.36 idi. Lepidik, asiner, papiller, solid, mikropapiller ve musinoz paternde uyum sırasıyla 0,34, 0,28, 0,30, 0,80, 0,16, 0,38 (p<0,001, p<0,001, p<0,001, p<0,001, p<0,001, p<0,001) idi. Hicbir olgu in situ adenokarsinom tanısı almadı. Minimal invaziv adenokarsinom ve invaziv adenokarsinom tanısı icin değerlendiriciler arasındaki uyum duşuktu (kappa değeri 0,17 (p<0,001)). Sonuç: Patologlar arası akciğer adenokarsinomunu baskın patern saptamasında uyum orta duzeyde bulundu. Minimal invaziv adenokarsinom ile İAK arası uyum ise duşuk duzeyde idi. Histolojik patern kriterleri daha acık ve daha detaylı olarak tanımlanmalıdır. Eğitim programları ve cok merkezli calışmalar tanıların standardizasyon ve uyumunu geliştirilebilir.


Seminars in Thoracic and Cardiovascular Surgery | 2018

Surgical Treatment of Pulmonary Complications in Behçet's Syndrome

Hasan Tüzün; Emire Seyahi; Gul Guzelant; Buge Oz; Sebnem Batur; Özkan Demirhan; Vedat Hamuryudan

We described disease characteristics, management and outcome of a group of Behçets syndrome (BS) patients who underwent pulmonary lobectomy, segmentectomy or various pleura interventions for complications due to pulmonary artery or descending aorta involvement. There were 9 patients with BS (8 M/1 F; mean age: 24.8 ± 7.5 and mean disease duration: 4.3 ± 3.8 years) who underwent lung surgery from 2000 to 2017. Their medical files including operation details and radiological and pathological studies were reviewed retrospectively. Lobectomy was done in 6 patients, decortications and pleura interventions in the remaining 3. The reason for the surgical procedures were giant pulmonary arterial aneurysms refractory to the medical treatment (n = 4), pneumothorax due to large cavities (n = 2), pleural effusions refractory to the medical treatment (n = 1), a bronchopleural fistula after embolization (n = 1) and bronchiectasis (n = 1). All patients received medical treatment with cyclophosphamide and corticosteroids before the surgical interventions. The histological examination in patients with pseudo-aneurysms showed destruction of medial elastic fibers, inflammatory cell infiltration of adventitial tissues and penetration into the adjacent bronchi with adherent thrombi. Two patients died: one due to Budd-Chiari syndrome 1 year after the surgery, another because of a massive hemoptysis 3 months after lobectomy. The remaining 7 patients are still alive with a median follow-up of 8 years (inter-quartile range [IQR]: 4-11). Lobectomies in BS patients with giant pulmonary aneurysms refractory to medical treatment can be done with favorable outcome. Also, complications such as large cavities causing pneumothorax, refractory pleural effusions, bronchiectasis, and embolization complications can be managed effectively with surgical interventions.


Diagnostic and interventional radiology | 2017

Evaluation of anterior mediastinal solid tumors by CT perfusion: a preliminary study.

Selim Bakan; Sedat Giray Kandemirli; Atilla Suleyman Dikici; Ezel Ersen; Onur Yıldırım; Cesur Samanci; Sebnem Batur; Deniz Cebi Olgun; Fatih Kantarci; Canan Akman

PURPOSE We aimed to assess the role of computed tomography (CT) perfusion in differentiation of thymoma from thymic hyperplasia, lymphoma, thymic carcinoma, and lung cancer invading anterior mediastinum. METHODS In this study, 25 patients with an anterior mediastinal lesion underwent CT perfusion imaging from January 2015 to February 2016. Diagnoses included thymoma (n=7), thymic hyperplasia (n=8), lymphoma (n=4), thymic carcinoma (n=3), and invasive lung cancer (n=3). Lymphoma, thymic carcinoma, and lung cancer were grouped as malignant tumors for statistical analysis. Values for blood flow, blood volume, and permeability surface were measured in CT perfusion. RESULTS Blood flow and blood volume values were higher in thymoma in comparison to thymic hyperplasia; however, the difference was not statistically significant. Blood volume values were significantly higher in thymoma (mean, 11.4 mL/100 mL; range, 5.2-20.2 mL/100 mL) compared with lymphoma (mean, 5.3 mL/100 mL; range, 2.5-7.2 mL/100 mL) (P = 0.023). Blood flow and blood volume values were significantly higher in thymoma compared with non-thymoma malignant tumors (P = 0.025). CONCLUSION CT perfusion is helpful in differentiating thymoma from non-thymoma malignancies including lymphoma, thymic carcinoma, and invasive lung cancer involving the anterior mediastinum.


Bosnian Journal of Basic Medical Sciences | 2016

Human epidermal growth factor receptor 2 (HER-2) status evaluation in advanced gastric cancer using immunohistochemistry versus silver in situ hybridization

Nuray Kepil; Sebnem Batur; Ceyda Sonmez Wetherilt; Sibel Erdamar Cetin

Accurate identification of human epidermal growth factor receptor 2 (HER-2) status in advanced gastric cancer patients is of utmost importance in terms of treatment planning. This study aimed to examine the HER-2 status in advanced gastric cancer patients using both immunohistochemistry (IHC) and silver in situ hybridization (SISH) techniques and to investigate concordance and diagnostic accuracy. In addition, associations between clinical parameters and HER 2 status were examined. A total of 313 patients diagnosed with locally advanced (Stage III: T3-4, N+) recurrent or metastatic adenocarcinoma of the stomach or esophagogastric junction, between 2009 and 2015, were included. HER-2 status was examined using both IHC and SISH techniques and the findings were compared. Overall SISH-confirmed HER-2 positivity rate was 22%. Multivariate analysis identified only well-differentiated tumor as a significant predictor of HER-2 positivity (OR: 2.9, 95% CI: 1.4-5.9, p = 0.003). When IHC 2+ and 3+ were considered positive for HER-2 status, sensitivity, specificity, and concordance rate (κ) was 95.7%, 93.8%, and 0.84, respectively. Corresponding figures when only IHC 3+ cases were considered positive were lower: 50%, 100%, and 0.61, respectively. The present method used for the identification of HER-2 positive gastric cancer patients provides satisfactory results. However, better categorization of IHC 2+ cases has the potential to improve the diagnostic accuracy, which is particularly important when more sophisticated methods are not readily available.


Pediatric Rheumatology | 2014

A rare pediatric tumor: thymic carcinoma mimicking acute rheumatoid fever

Muferet Erguven; Asım Yörük; Olcay Yasa; Mehpare Yanartas; Sebnem Batur; Buge Oz

Malign diseases may mimic rheumatoid diseases. Joint involvement and leg pain are among frequently encountered symptoms particularly in the patients with leukemia. Sometimes, however, primary tumor may be asymptomatic and may mimic rheumatoid diseases because of metastasis. The present case, which admitted to our clinic with bone and joint pain continuing for 10 days and mimicking acute rheumatoid fever (ARF) and in which bone metastasis due to thymic carcinoma was detected when investigated, was presented for it is a rare condition.


Tumor Biology | 2014

Analysis of PTEN, BRAF and PI3K status for determination of benefit from cetuximab therapy in metastatic colorectal cancer patients refractory to chemotherapy with wild-type KRAS

Deniz Tural; Sebnem Batur; Sibel Erdamar; Emre Akar; Nuray Kepil; Nil Molinas Mandel; Suheyla Serdengecti


International Journal of Clinical and Experimental Pathology | 2013

Primary central nervous system lymphoma in immunocompetent individuals: a single center experience.

Hilal Aki; Didem Uzunaslan; Caner Saygin; Sebnem Batur; Nukhet Tuzuner; Ali Metin Kafadar; Seniz Ongoren; Buge Oz

Collaboration


Dive into the Sebnem Batur's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge